Third, the patient cohort in our study (16 healthy donors, 48 CRC patients, and 29 CRC patients after surgery) is not large enough; further investigations in a larger‐scale cohort are required to explore the clinical utility of CD147 and A33 on fEVs for CRC screening. The gene discussed is BSG; the disease is colorectal carcinoma.